UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000026259
Receipt No. R000029322
Scientific Title Phase II study for efficacy and safety of pembrolizumab for chemotherapy unfit previously untreated patients highly expressing PD-L1 positive advanced non-small cell lung cancer
Date of disclosure of the study information 2017/03/27
Last modified on 2019/03/22 12:23:43

No. Disposal Last modified on Item of update
1 Insert 2017/02/21 23:20:24
2 Update 2017/03/25 10:10:16 Recruitment status
3 Update 2017/03/25 10:10:48 Date of disclosure of the study information
4 Update 2017/05/04 01:34:53 Anticipated trial start date
5 Update 2017/07/17 16:36:11 Recruitment status
Anticipated trial start date
6 Update 2018/05/20 10:03:53 Recruitment status
7 Update 2019/03/22 12:22:07 Date of IRB
Last follow-up date
8 Update 2019/03/22 12:23:43 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Division name
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email


Contact us.